Shopping Cart 0
Cart Subtotal
USD 0

Reckitt Benckiser Group Plc (RB.) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Reckitt Benckiser Group Plc (RB) is a consumer health and hygiene company that manufactures and markets household, toiletry and health care products. These consist of air fresheners, laundry products, dishwashing detergents, disinfectant sprays, water softeners, household cleaners, and personal care products. It also sells over-the-counter (OTC) drugs, cough and congestion tablets. Sinus relief products, gastric liquids, hair removal and pest control products. The company markets these products under various Powerbrands including Nurofen, Strepsils, Mucinex, Dettol, Lysol, Veet, Harpic, Mortein, Finish and Vanish, for a few. It has operations across Asia Pacific, Europe, North America and the Middle East and Africa regions. RB is headquartered in Slough, Berkshire, the UK.

Reckitt Benckiser Group Plc (RB.)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12

Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14

Partnerships 15

Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15

Licensing Agreements 17

Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17

Asset Transactions 19

G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19

Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 20

Acquisition 21

Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For USD 3.2 Billion 21

Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For USD 1.4 Billion 22

SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24

Reckitt Benckiser Group Plc-Key Competitors 25

Reckitt Benckiser Group Plc-Key Employees 26

Reckitt Benckiser Group Plc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 30

Financial Announcements 30

Feb 19, 2018: Reckitt Benckiser reports full year 2017 results 30

Jul 24, 2017: Reckitt Benckiser reports half year 2017 results 33

Legal and Regulatory 34

Mar 08, 2017: Absorption Pharmaceuticals: Maker of Premature Ejaculation Medication Promescent Files Suit Against British Conglomerate for Trade Secret Theft and Fraud 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12

Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14

Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15

Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17

G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19

Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 20

Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For USD 3.2 Billion 21

Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For USD 1.4 Billion 22

SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24

Reckitt Benckiser Group Plc, Key Competitors 25

Reckitt Benckiser Group Plc, Key Employees 26

Reckitt Benckiser Group Plc, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Reckitt Benckiser Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Reckitt Benckiser Group Plc (RB) is a consumer health and hygiene company that manufactures and markets household, toiletry and health care products. These consist of air fresheners, laundry products, dishwashing detergents, disinfectant sprays, water softeners, household cleaners, and personal care products. It also sells over-the-counter (OTC) drugs, cough and congestion tablets. Sinus relief products, gastric liquids, hair removal and pest control products. The company markets these products under various Powerbrands including Nurofen, Strepsils, Mucinex, Dettol, Lysol, Veet, Harpic, Mortein, Finish and Vanish, for a few. It has operations across Asia Pacific, Europe, North America and the Middle East and Africa regions. RB is headquartered in Slough, Berkshire, the UK.

Reckitt Benckiser Group Plc (RB.)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12

Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14

Partnerships 15

Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15

Licensing Agreements 17

Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17

Asset Transactions 19

G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19

Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 20

Acquisition 21

Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For USD 3.2 Billion 21

Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For USD 1.4 Billion 22

SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24

Reckitt Benckiser Group Plc-Key Competitors 25

Reckitt Benckiser Group Plc-Key Employees 26

Reckitt Benckiser Group Plc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 30

Financial Announcements 30

Feb 19, 2018: Reckitt Benckiser reports full year 2017 results 30

Jul 24, 2017: Reckitt Benckiser reports half year 2017 results 33

Legal and Regulatory 34

Mar 08, 2017: Absorption Pharmaceuticals: Maker of Premature Ejaculation Medication Promescent Files Suit Against British Conglomerate for Trade Secret Theft and Fraud 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Reckitt Benckiser Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10

Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12

Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14

Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15

Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17

G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19

Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 20

Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For USD 3.2 Billion 21

Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For USD 1.4 Billion 22

SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24

Reckitt Benckiser Group Plc, Key Competitors 25

Reckitt Benckiser Group Plc, Key Employees 26

Reckitt Benckiser Group Plc, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Reckitt Benckiser Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.